Skandinaviska Enskilda Banken Ab (Publ) Liquidia Corp Transaction History
Skandinaviska Enskilda Banken Ab (Publ)
- $24.3 Billion
- Q3 2025
A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in Liquidia Corp stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 1,317 shares of LQDA stock, worth $33,148. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,317Holding current value
$33,148% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LQDA
# of Institutions
222Shares Held
49.3MCall Options Held
1.61MPut Options Held
1.15M-
Black Rock Inc. New York, NY4.24MShares$107 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.24MShares$107 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.96MShares$99.7 Million0.0% of portfolio
-
Findell Capital Management LLC New York, NY3MShares$75.5 Million18.2% of portfolio
-
Opaleye Management Inc. Boston, MA2.48MShares$62.3 Million7.37% of portfolio
About Liquidia Corp
- Ticker LQDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,362,300
- Market Cap $1.62B
- Description
- Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...